UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported) April 21, 2016
THE MACERICH COMPANY
(Exact Name of Registrant as Specified in Charter)
MARYLAND |
|
1-12504 |
|
95-4448705 |
(State or Other Jurisdiction of |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
Incorporation) |
|
|
|
|
401 Wilshire Boulevard, Suite 700, Santa Monica, California |
|
90401 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrants telephone number, including area code (310) 394-6000
N/A
(Former Name or Former Address, if Changed Since Last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
x Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On April 21, 2016, the Board of Directors (the Board) of The Macerich Company (the Company) adopted amendments to the Companys Amended and Restated Bylaws (the Bylaws), effective immediately, to implement new proxy access provisions that would apply to annual meetings of stockholders after the 2016 annual meeting. As amended, the Bylaws will permit eligible stockholders, including qualifying groups of up to 20 stockholders, that have continuously owned at least 3% of the Companys outstanding common stock for at least three years to nominate director nominees constituting up to the greater of two directors and 20% of the number of directors serving on the Board, and have such nominees included in the Companys proxy materials, provided that the stockholder(s) and the nominee(s) satisfy the requirements specified in the amended Bylaws and subject to the terms and conditions therein.
The Bylaws were also amended to make various conforming and administrative revisions to the advance notice requirements for stockholder business and nominations in Article I, Section 1.11.
The foregoing description of the Companys Bylaws does not purport to be complete and is qualified in its entirety by reference to the full text of the Bylaws, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Item 8.01. Other Events.
The disclosure set forth in Item 5.03 above is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits
Exhibit No. |
|
Description |
3.1 |
|
Amended and Restated Bylaws of The Macerich Company, as adopted on April 21, 2016. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, The Macerich Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
THE MACERICH COMPANY | ||
|
|
|
| |
|
|
By: |
THOMAS J. LEANSE | |
|
|
|
| |
|
|
|
| |
April 26, 2016 |
|
By: |
/s/ Thomas J. Leanse | |
Date |
|
|
Name: |
Thomas J. Leanse |
|
|
|
Title: |
Senior Executive Vice President, |